OrganOx sold for $1.5bn after creating device that keeps donor livers alive longer
BGF - 25-Oct-2025The deal shows how long-term backing can help medical ideas reach real patients
Join the club for FREE to access the whole archive and other member benefits.
Organ donation and medical equipment manufacturing company
OrganOx is at the forefront of changing the way donor organs are preserved in the critical time between donation and transplantation. Our leading product, the metra®, harnesses patented normothermic machine perfusion technology to preserve donor livers for up to 24 hours prior to transplant.
Our Chief Medical Officer, Professor Peter Friend, and colleagues heralded the start of the normothermic machine perfusion revolution in liver transplantation with a first publication in 2002.2 Since then, over 50 publications have supported the patented OrganOx technology demonstrating its advantages over conventional cold storage and cold perfusion technologies.
Visit website: https://www.organox.com/
Details last updated 12-Sep-2022
The deal shows how long-term backing can help medical ideas reach real patients
Liver ICU main aim-Improve liver transplant processes and discover therapies for liver diseases